_version_ 1784757115224588288
author Sora, Federica
Giammarco, Sabrina
Raiola, Anna Maria
Di Grazia, Carmen
Bregante, Stefania
Gualandi, Francesca
Varaldo, Riccardo
Chiusolo, Patrizia
Sica, Simona
Laurenti, Luca
Innocenti, Idanna
Autore, Francesco
Metafuni, Elisabetta
Galli, Eugenio
Bacigalupo, Andrea
Angelucci, Emanuele
author_facet Sora, Federica
Giammarco, Sabrina
Raiola, Anna Maria
Di Grazia, Carmen
Bregante, Stefania
Gualandi, Francesca
Varaldo, Riccardo
Chiusolo, Patrizia
Sica, Simona
Laurenti, Luca
Innocenti, Idanna
Autore, Francesco
Metafuni, Elisabetta
Galli, Eugenio
Bacigalupo, Andrea
Angelucci, Emanuele
author_sort Sora, Federica
collection PubMed
description
format Online
Article
Text
id pubmed-9325705
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93257052022-07-28 Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant Sora, Federica Giammarco, Sabrina Raiola, Anna Maria Di Grazia, Carmen Bregante, Stefania Gualandi, Francesca Varaldo, Riccardo Chiusolo, Patrizia Sica, Simona Laurenti, Luca Innocenti, Idanna Autore, Francesco Metafuni, Elisabetta Galli, Eugenio Bacigalupo, Andrea Angelucci, Emanuele Blood Cancer J Correspondence Nature Publishing Group UK 2022-07-26 /pmc/articles/PMC9325705/ /pubmed/35882842 http://dx.doi.org/10.1038/s41408-022-00701-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Sora, Federica
Giammarco, Sabrina
Raiola, Anna Maria
Di Grazia, Carmen
Bregante, Stefania
Gualandi, Francesca
Varaldo, Riccardo
Chiusolo, Patrizia
Sica, Simona
Laurenti, Luca
Innocenti, Idanna
Autore, Francesco
Metafuni, Elisabetta
Galli, Eugenio
Bacigalupo, Andrea
Angelucci, Emanuele
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
title Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
title_full Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
title_fullStr Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
title_full_unstemmed Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
title_short Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
title_sort predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325705/
https://www.ncbi.nlm.nih.gov/pubmed/35882842
http://dx.doi.org/10.1038/s41408-022-00701-w
work_keys_str_mv AT sorafederica predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT giammarcosabrina predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT raiolaannamaria predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT digraziacarmen predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT bregantestefania predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT gualandifrancesca predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT varaldoriccardo predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT chiusolopatrizia predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT sicasimona predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT laurentiluca predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT innocentiidanna predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT autorefrancesco predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT metafunielisabetta predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT gallieugenio predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT bacigalupoandrea predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant
AT angelucciemanuele predictingtheoutcomeforpatientswithmyelofibrosisundergoinganallogeneichemopoieticstemcelltransplant